FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

564311000001105: Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16893101000001110 Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
65937201000001119 Mizollen 10mg modified-release tablets (Sanofi) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) Is a Mizolastine 10mg m/r tablet false Inferred relationship Existential restriction modifier
Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) Has active ingredient Mizolastine true Inferred relationship Existential restriction modifier
Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) Is a Mizolastine 10mg modified-release tablets true Inferred relationship Existential restriction modifier
Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) Is a Mizollen true Inferred relationship Existential restriction modifier
Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) Has specific active ingredient Mizolastine true Inferred relationship Existential restriction modifier
Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) Is a Mizolastine 10mg modified-release tablets false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) 30 tablet 2 x 15 tablets Is pack of False Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) Inferred relationship Existential restriction modifier
Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) 30 tablet 2 x 15 tablets Has AMP True Mizollen 10mg modified-release tablets (Schwarz Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start